Explore 3 Stock Ideas & Industry Insights Download Free Report

CanadaBis Capital Inc

Healthcare CA CANB

0.015CAD
0.00(0%)

Last update at 2026-06-02T13:30:00Z

Day Range

0.010.01
LowHigh

52 Week Range

0.010.10
LowHigh

Fundamentals

  • Previous Close 0.01
  • Market Cap2.12M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA0.48M
  • Revenue TTM15.08M
  • Revenue Per Share TTM0.11
  • Gross Profit TTM 6.73M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Type yearly yearly yearly yearly yearly
Date 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Income before tax -0.72188M 0.68M 4.56M 0.61M -2.68091M
Minority interest 0.00000M 0.00000M 0.00000M 0.00038M 0.00414M
Net income -0.83520M 0.60M 4.44M 0.61M -2.67677M
Selling general administrative 6.55M 7.45M 6.76M 4.23M 4.48M
Selling and marketing expenses - - - - -
Gross profit 7.38M 8.82M 11.78M 5.57M 2.52M
Reconciled depreciation 0.88M 0.90M 0.67M 0.53M 0.47M
Ebit - - 5.01M 1.10M -2.28137M
Ebitda - - 5.68M 1.63M -1.81245M
Depreciation and amortization - - 0.67M 0.53M 0.47M
Non operating income net other - - - - -
Operating income 0.45M 0.83M 4.68M 1.04M -2.28565M
Other operating expenses - - 17.55M 10.63M 9.15M
Interest expense 0.64M 0.51M 0.45M 0.49M 0.40M
Tax provision 0.11M 0.08M 0.12M 0.00000M -
Interest income - - - - -
Net interest income -0.63820M -0.50985M -0.44611M -0.49263M -0.39954M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - 0.12M 0.56M 0.40M
Total revenue 16.90M 17.95M 22.22M 11.67M 6.87M
Total operating expenses 16.45M 17.12M 7.11M 4.53M 4.80M
Cost of revenue 9.52M 9.13M 10.44M 6.10M 4.35M
Total other income expense net -0.53787M 0.36M 0.33M 0.06M 0.00428M
Discontinued operations - - - - -
Net income from continuing ops -0.83520M 0.60M 4.44M 0.61M -2.68091M
Net income applicable to common shares - - - 0.61M -2.67677M
Preferred stock and other adjustments - - - - -
Breakdown 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Type yearly yearly yearly yearly yearly
Date 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Total assets 24.54M 24.55M 22.96M 15.48M 13.28M
Intangible assets - - - - 0.00771M
Earning assets - - - - -
Other current assets - - - 0.06M 0.03M
Total liab 16.62M 16.45M 15.62M 12.84M 11.46M
Total stockholder equity 7.83M 8.00M 7.25M 2.54M 1.73M
Deferred long term liab - - - - -
Other current liab - - - 0.77M 0.70M
Common stock - - - 16.15M 16.00M
Capital stock 16.75M 16.75M 16.73M 16.15M 16.00M
Retained earnings -13.38738M -11.86782M -12.46811M -16.91260M -17.52094M
Other liab - - - 0.04M 0.06M
Good will - - - - -
Other assets - - - 0.29M 0.29M
Cash 0.83M 1.68M 3.23M 0.14M 0.85M
Cash and equivalents - - - - -
Total current liabilities 13.85M 11.91M 9.68M 11.90M 10.14M
Current deferred revenue - - - - -
Net debt 6.27M 3.76M 2.75M 7.08M 6.59M
Short term debt - - - - -
Short long term debt 4.61M 1.54M 1.01M 6.75M 6.99M
Short long term debt total - - - - -
Other stockholder equity - - - 3.31M 3.25M
Property plant equipment - - - 9.51M 10.09M
Total current assets 14.69M 13.72M 11.63M 5.68M 2.90M
Long term investments - - - - -
Net tangible assets - - - 2.54M 1.72M
Short term investments - - - - -
Net receivables 1.43M 1.98M 1.81M 2.14M 0.67M
Long term debt 2.49M 3.90M 4.97M 0.47M 0.46M
Inventory 11.42M 9.26M 5.83M 2.93M 1.22M
Accounts payable 7.11M 8.06M 6.43M 3.54M 1.33M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 9.85M 10.83M 11.33M 9.80M 10.38M
Capital lease obligations 0.65M 1.00M 1.33M 0.59M 1.00M
Long term debt total - - - - -
Breakdown 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Type yearly yearly yearly yearly yearly
Date 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Investments - -0.32833M -0.96582M -0.20977M 0.12M
Change to liabilities - - - 2.19M -0.61421M
Total cashflows from investing activities - - - -0.20977M 0.12M
Net borrowings 2.41M -0.93928M - -1.02849M 2.05M
Total cash from financing activities 2.52M -0.96203M -1.50170M -0.41209M 2.37M
Change to operating activities - - - -0.25120M 0.20M
Net income -0.83520M -0.08407M 4.44M 0.61M -2.67677M
Change in cash -0.84747M -1.54666M 3.08M -0.70463M 0.68M
Begin period cash flow 1.68M 3.23M 0.14M 0.85M 0.17M
End period cash flow 0.83M 1.68M 3.23M 0.14M 0.85M
Total cash from operating activities -3.19599M -0.25631M 5.55M -0.08277M -1.80666M
Issuance of capital stock 0.00000M 0.00900M 0.21M 0.15M 0.54M
Depreciation 0.88M 0.90M 0.67M 0.53M 0.47M
Other cashflows from investing activities - - - - 0.27M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M -
Change to inventory -2.22321M -3.42283M -2.97840M -1.81286M -0.16640M
Change to account receivables 0.62M -0.06385M 0.14M -1.46644M 0.40M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - -0.00105M -0.22500M
Change to netincome - - - 0.12M 0.58M
Capital expenditures 0.17M 0.34M 0.98M 0.21M 0.15M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -3.90107M -1.37705M 0.09M -1.33798M -0.15777M
Stock based compensation 0.00000M 0.14M 0.05M 0.05M 0.46M
Other non cash items 0.39M -0.01568M 0.13M 0.04M -0.02510M
Free cash flow -3.36564M -0.59448M 4.57M -0.29254M -1.95899M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
CANB
CanadaBis Capital Inc
- -% 0.01 - - 0.14 0.28 0.58 17.65
RX
Biosyent Inc.
0.12 0.87% 13.95 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc
-0.005 4.17% 0.12 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation
- -% 0.50 - - 108.48 4.41 140.29 -4.258
LSL
LSL Pharma Group Inc.
- -% 0.33 20.75 - 1.88 1.89 2.85 10.19

Reports Covered

Stock Research & News

Profile

CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through two segments: Cultivation and Extraction. The company cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. It is also involved in the production and wholesale distribution of cannabis extract products through the Company's manufacturing facilities to licensed distributors and cannabis producers. CanadaBis Capital Inc. was formerly known as 1926360 Alberta Ltd. and changed its name to CanadaBis Capital Inc. in April 2019. CanadaBis Capital Inc. was incorporated in 2016 and is based in Red Deer County, Canada.

CanadaBis Capital Inc

255C Clearview Drive, Red Deer County, AB, Canada, T4E 3B6

Key Executives

Name Title Year Born
Mr. Travis Gerald McIntyre Pres, CEO & Director 1981
Mr. Shane Chana C.A., CPA CFO & Director 1986
Ms. Barbara O'Neill Corp. Sec. & Director 1967
Mr. Travis Gerald McIntyre President, CEO & Director 1981
Mr. Garfield Richards C.A., CPA Chief Financial Officer NA
Ms. Barbara Michele O'Neill Corporate Secretary & Director 1967
Mr. Shane Chana C.A., CPA Director & Interim CFO 1986
Mr. Travis Gerald McIntyre President, CEO & Director 1982
Mr. Shane Chana C.A., CPA Director & Interim CFO 1987

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.